EU Authorized Representative for Defibrillator Manufacturers: Rule 22 Class III, Rule 9 Class IIb and the Mandate
Automated and semi-automatic external defibrillators are class III under Rule 22 of Annex VIII to Regulation (EU) 2017/745, because their rhythm analysis decides whether a shock is delivered. A manual defibrillator without that function is class IIb under Rule 9, and an implantable cardioverter defibrillator is class III under Rule 8. A notified body is involved in every case, and a manufacturer outside the EU must designate a sole authorized representative under Article 11(1).
Which products this page covers
This page covers automated external defibrillators (AEDs) for public access and home use, semi-automatic and manual external defibrillators used by professionals, wearable cardioverter defibrillators, defibrillator pads and electrodes, and the programmers used with implantable cardioverter defibrillators. Implantable cardioverter defibrillators (ICDs) themselves are active implantable devices and are mentioned for completeness. Three rules of Annex VIII apply, and the class depends on whether the device decides for itself when to deliver a shock.
Rule 9: manual external defibrillators
A manual defibrillator delivers electrical energy to the heart on the operator's command. It is an active therapeutic device under Rule 9 of Annex VIII:
"All active therapeutic devices intended to administer or exchange energy are classified as class IIa unless their characteristics are such that they may administer energy to or exchange energy with the human body in a potentially hazardous way, taking account of the nature, the density and site of application of the energy, in which case they are classified as class IIb."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 9
MDCG 2021-24 lists external pacemakers and external defibrillators with no integrated or incorporated diagnostic function under the class IIb branch of Rule 9, next to high-frequency electrosurgical generators. The energy delivered across the chest is potentially hazardous in the sense of the rule, so the class IIa branch does not apply.
Rule 22: automated and semi-automatic external defibrillators
Rule 22 was written with AEDs in view:
"Active therapeutic devices with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as closed loop systems or automated external defibrillators, are classified as class III."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 22
The guidance lists automated external defibrillators (AED) including their pads/electrodes and semiautomatic external defibrillators as class III examples. The rhythm analysis that decides whether a shock is advised is the integrated diagnostic function that determines patient management. A manual defibrillator that also offers an AED mode is class III, because Section 3.5 of Annex VIII applies the stricter rule.
Rule 8 and Rule 9: implantable defibrillators and their programmers
An ICD is an active implantable device:
"are active implantable devices or their accessories, in which cases they are classified as class III;"
Source: Regulation (EU) 2017/745, Annex VIII, Rule 8, sixth indent
MDCG 2021-24 lists implantable cardioverter defibrillators (ICD) and the leads, electrodes and adaptors for implantable defibrillators under that indent, and adds in its note that non-implantable and non-active accessories to active implantable devices should also be class III under Rule 8. The programmer is reached by the last paragraph of Rule 9:
"All active devices that are intended for controlling, monitoring or directly influencing the performance of active implantable devices are classified as class III."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 9
The guidance names the programmer for an implantable cardioverter defibrillator as a class III example under that paragraph.
Classification table
| Product variant | Class | Rule | Notified body |
|---|---|---|---|
| Automated external defibrillator (AED), including pads and electrodes | III | Annex VIII, Rule 22 | Yes, Annex IX or Annex X plus XI |
| Semi-automatic external defibrillator | III | Annex VIII, Rule 22 | Yes |
| Manual external defibrillator with no integrated diagnostic function | IIb | Annex VIII, Rule 9, second branch | Yes |
| Manual defibrillator with AED mode | III | Annex VIII, Rule 22; Section 3.5 | Yes |
| Wearable cardioverter defibrillator with automatic rhythm analysis | III | Annex VIII, Rule 22 | Yes |
| Implantable cardioverter defibrillator (ICD) and its leads | III | Annex VIII, Rule 8, active implantable indent | Yes, every device |
| Programmer for an ICD | III | Annex VIII, Rule 9, last paragraph | Yes |
Notified body involvement
Class III devices follow Article 52(3), with the notified body assessing the technical documentation of every device:
"Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI."
Source: Regulation (EU) 2017/745, Article 52(3)
A manual class IIb defibrillator follows Article 52(4), with the technical documentation of at least one representative device per generic device group assessed. ICDs are implantable and additionally carry the implant card obligations of Article 18 and the 15-year retention period of Article 10(8).
The authorized representative: Article 11
Whether a defibrillator manufacturer needs an EU authorized representative does not depend on the class of the product. It depends on where the manufacturer is established. Article 11(1) is the operative sentence:
"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative."
Source: Regulation (EU) 2017/745, Article 11(1)
Article 11(2) requires the mandate to be accepted in writing and to cover at least all devices of the same generic device group. Article 11(3) then lists the minimum tasks. For an AED manufacturer the representative holds a class III certificate and, under Article 11(3)(g), passes on every report of a device that failed to deliver or advise a shock without delay.
"(a) verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
Source: Regulation (EU) 2017/745, Article 11(3)(a)
"(b) keep available a copy of the technical documentation, the EU declaration of conformity and, if applicable, a copy of the relevant certificate, including any amendments and supplements, issued in accordance with Article 56, at the disposal of competent authorities for the period referred to in Article 10(8);"
Source: Regulation (EU) 2017/745, Article 11(3)(b)
"(g) immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"
Source: Regulation (EU) 2017/745, Article 11(3)(g)
One mandate for the European Union and Türkiye
Medex is established in Türkiye and registered in EUDAMED as an authorized representative under SRN TR-AR-000057550, so a defibrillator manufacturer outside both the EU and Türkiye covers both markets with one mandate. MDCG 2022-16, footnote 1:
"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey."
Source: MDCG 2022-16, Guidance on Authorised Representatives, footnote 1
The Commission's Notice to Stakeholders of March 2022 draws the conclusion:
"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey."
Source: European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices, Section I.2
Placing the product on the Turkish market also requires registration in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, a separate service under a separate contract: see ÜTS registration for foreign manufacturers and defibrillator ÜTS registration in Türkiye (Turkish).
What Medex does under the mandate
We verify that the EU declaration of conformity and technical documentation for each defibrillator device exist and that the notified body procedure has been carried out, keep copies for the period in Article 10(8), register in EUDAMED and check your Basic UDI-DI records, answer competent authority requests, cooperate on corrective actions and pass complaints and suspected incidents to you without delay. A person responsible for regulatory compliance is available in-house.
A class III AED falls in the band of €1,500 to 2,000 per year and a class IIb manual defibrillator in the band of €1,200 to 1,600 per year, fixed for three years from signature. Setup is €0 and a change of representative costs nothing; see pricing and EU authorized representative cost. We do not perform electrical safety testing or evaluate shock algorithms. We are not a notified body and we do not find importers or distributors. Offices in Ankara and İstanbul.
The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.
Related pages
Related cardiac and active devices with their own pages include ECG devices, ventilators and CPAP and stents. All groups are listed on the medical device categories page. The general guide is EU authorized representative.
Frequently asked questions
What class is an AED under the MDR?
Class III. Rule 22 of Annex VIII names automated external defibrillators as active therapeutic devices with an integrated diagnostic function that significantly determines patient management. MDCG 2021-24 lists AEDs including their pads and electrodes, and semiautomatic external defibrillators, as class III.
Is a manual defibrillator also class III?
No, unless it has an AED mode. MDCG 2021-24 lists external defibrillators with no integrated or incorporated diagnostic function under the class IIb branch of Rule 9. A manual device with an automatic analysis mode is class III under Rule 22 and Section 3.5.
Are AED pads and electrodes classified with the AED?
MDCG 2021-24 lists automated external defibrillators (AED) including their pads/electrodes as the class III example under Rule 22. Accessories are classified in their own right under Section 3.2, and the guidance places these with the AED.
What route applies to an ICD?
Class III under the active implantable indent of Rule 8, with conformity assessment under Article 52(3), the implant card obligations of Article 18 and a documentation retention period of at least 15 years under Article 10(8).
Does one Medex mandate cover the EU and Türkiye for defibrillators?
Yes. MDCG 2022-16 notes that the Union market extends via the Customs Union Agreement to Turkey, and the Commission Notice of March 2022 confirms that one authorized representative, in the EU or in Türkiye, is enough for a manufacturer outside both.
Sources and further reading
Regulation (EU) 2017/745 on medical devices, consolidated text: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20250110
MDCG 2021-24, Guidance on classification of medical devices: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
MDCG 2022-16, Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022): health.ec.europa.eu/system/files/2022-04/md_eu-turkey_customs-union_en.pdf
Request a fixed-price EU authorized representative quote for your defibrillators.
Request a proposal · View pricing · Appoint Medex as your authorized representative
